🔎 Trials Near Me

Почетна › Затајење срца › Alabama

Kliničke studije za Затајење срца u državi Alabama

20 studija za Затајење срца traži učesnike na lokacijama u državi Alabama.

Gradovi u državi Alabama

Zvanični tekst studije (na engleskom)

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Diagnostic and Medical Clinic, Mobile
  • Mobile Heart Specialists, PC, Mobile
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06424288

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

  • Cardiology Associates of Mobile, Mobile
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07232030

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Birmingham
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT00271180

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Advanced Cardiovascular, LLC, Alexander City
  • University of Alabama at Birmingham, Birmingham
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06736574

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  • Heart Center Research, LLC, Huntsville
  • Mobile Infirmary Medical Center, Mobile
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07069738

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • University of Alabama Saint Vincent's Birmingham, Birmingham
  • SEC Clinical Research, Dothan
  • Eastern Shore Research Institute, Fairhope
  • и још 1
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459

Assessment of CCM in HF With Higher Ejection Fraction

  • Grandview Medical Group Research, LLC, Birmingham
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05064709

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Birmingham
  • Research Site, Centreville
  • Research Site, Fairhope
  • и још 4
Тражи се учесникФаза 3
Узраст 40 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06677060

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 1, Birmingham
Тражи се учесникФаза 2
Узраст од 30 до 84 · Оба пола · Ажурирано 13. 10. 2026. · NCT07795814

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Alexander City
  • Research Site, Fairhope
  • Research Site, Huntsville
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 13. 10. 2026. · NCT06307652

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
Тражи се учесник
Узраст 60 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05996328

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

  • Univ of Alabama Birmingham, Birmingham
Тражи се учесникФаза 2
Узраст од 40 до 84 · Оба пола · Ажурирано 5. 10. 2026. · NCT06979362

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Fairhope
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07761117

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10004 Fairhope, AL Investigational Site, Fairhope
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Birmingham, AL Investigative Site 10012, Birmingham
  • Fairhope, AL Investigative Site 10004, Fairhope
  • Huntsville, AL Investigative Site 10026, Huntsville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06008197

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Eastern Shore Research Institute, LLC, Fairhope
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 27. 8. 2026. · NCT06793371

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Advanced Cardiovascular, LLC, Alexander City
  • Univ of Alabama Birmingham, Birmingham
  • Eastern Shore Rsrch Inst, LLC, Fairhope
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10004 Fairhope, AL Investigational Site, Fairhope
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT06033950

Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function

  • Auburn University, Auburn
Тражи се учесник
Узраст 55 и старији · Оба пола · Ажурирано 25. 3. 2026. · NCT07489105

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

  • Heart Center Research, LLC, Huntsville
Тражи се учесникФаза 4
Узраст 19 и старији · Оба пола · Ажурирано 29. 1. 2024. · NCT06218199

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.